SCHEMBL6436243

SCHEMBL6436243

O=C(Cc1ccccn1)Nc1ccc(F)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA5A P35218 1/20 0.59
CA7 P43166 1/20 0.59
CA5B Q9Y2D0 1/20 0.59
NPC1 O15118 2/20 0.54
TP53 P04637 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.51
ROCK2 O75116 1/20 0.51
RAB9A P51151 2/20 0.50
NPY2R P49146 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 3/20 0.49
CRACR2A Q9BSW2 2/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HTR1A P08908 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3453018 0.81 CA1 (0.67) CA1CA2CA5ACA7CA5B
SCHEMBL2134679 0.81 RAB9A (0.67) CA1CA2CA5ACA7CA5B
SCHEMBL2028409 0.81 CA1 (0.69) CA1CA2CA5ACA7CA5B
SCHEMBL6491441 0.78 CA1 (0.71) CA1CA2CA5ACA7CA5B
SCHEMBL10576461 0.78 CA1 (0.67) CA1CA2CA5ACA7CA5B
SCHEMBL18546011 0.78 CA1 (0.66) CA1CA2CA5ACA7CA5B
SCHEMBL259393 0.78 NPC1 (0.67) CA1CA2CA5ACA7CA5B
SCHEMBL29765433 0.77 CA1 (0.65) CA1CA2CA5ACA7CA5B
SCHEMBL29217375 0.77 GRM4 (0.72) NPC1SMN1; SMN2RAB9AKDM4E
SCHEMBL15551102 0.76 NAMPT (0.72) CA1CA2CA5ACA7CA5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224163-B1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-03-30 EP disclosed
US-6548522-B1 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide HOFFMANN-LA ROCHE INC. 2003-04-15 US disclosed
EP-1224163-A1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001027070-A1 USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-19 WO disclosed